In contrast, syncytin-1 expression levels and syncytin-mediated cell-cell fusion were rather correlated to disease progression in urothelial cell carcinoma [59], endometrial carcinoma and pre-stages [61], colorectal cancer [64] and prostate cancer [66]. This evidence concerns the gene ERVW-1 and prostate cancer.